Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
Department of Health and Human Services
The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advanceadavnce mechanistic understanding of both biobehavioral and neurobiologfical pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD.
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Next 90 days
Posted
11/18/2024
Closes
2026-09-07
Eligibility
Eligibility
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationFor profit organizations other than small businessesOthers (see text field entitled "Additional Information on Eligibility" for clarification)City or township governmentsPublic and State controlled institutions of higher educationSpecial district governmentsIndependent school districtsNative American tribal governments (Federally recognized)State governmentsSmall businessesNative American tribal organizations (other than Federally recognized tribal governments)Private institutions of higher educationCounty governmentsPublic housing authorities/Indian housing authoritiesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Program
Funding area
Health - HL
Opportunity #
PAR-25-064
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov